Oncology in Clinical Practice · Published 2026-01-15 · DOI 10.5603/ocp.110777
INTRODUCTION: There are an increasing number of people living with a cancer diagnosis. This results in a growing burden on healthcare systems. Cancer prevalence is commonly used as a primary measure of this burden. The aim of this study is to assess cancer prevalence in Poland and to compare it with other European Union countries. MATERIAL AND METHODS: The analysis was based on data from ECIS, OECD, EUROCARE-6, and the Polish National Cancer Registry. Five-year and total cancer prevalence was standardized according to the ESP 2013, and was applied herein. RESULTS: Poland is characterized by a lower cancer prevalence than the EU average, although this has been accompanied by a rapid increase over the past two decades. CONCLUSIONS: Lower cancer prevalence does not imply a lower cancer burden. This indicator should be more widely used in planning oncological care.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →